Marsha D Rappley

Summary

Affiliation: Michigan State University
Country: USA

Publications

  1. ncbi Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder
    Marsha D Rappley
    Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA
    J Dev Behav Pediatr 23:23-30. 2002
  2. ncbi Clinical practice. Attention deficit-hyperactivity disorder
    Marsha D Rappley
    Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA
    N Engl J Med 352:165-73. 2005
  3. ncbi Attention-deficit/hyperactivity disorder in children and adolescents: interventions for a complex costly clinical conundrum
    Donald E Greydanus
    Department of Pediatrics and Human Development, Michigan State University College of Human Medicine, A110 East Fee Hall, East Lansing, MI 48824, USA
    Pediatr Clin North Am 50:1049-92, vi. 2003
  4. ncbi Low blood lead levels associated with clinically diagnosed attention-deficit/hyperactivity disorder and mediated by weak cognitive control
    Joel T Nigg
    Department of Psychology, Michigan State University, East Lansing, Lansing, MI 48824 1116, USA
    Biol Psychiatry 63:325-31. 2008
  5. ncbi Psychopharmacology of ADHD in adolescents
    Donald E Greydanus
    College of Human Medicine, Michigan State University, Kalamazoo Center for Medical Studies, Kalamazoo, Michigan 49008-1284, USA
    Adolesc Med 13:599-624. 2002
  6. ncbi Neuropsychological executive functions and DSM-IV ADHD subtypes
    Joel T Nigg
    Department of Psychology, Michigan State University, East Lansing 48824-1117, USA
    J Am Acad Child Adolesc Psychiatry 41:59-66. 2002
  7. ncbi Family adversity in DSM-IV ADHD combined and inattentive subtypes and associated disruptive behavior problems
    Carla A Counts
    Department of Psychology, Florida State University, Tallahassee, USA
    J Am Acad Child Adolesc Psychiatry 44:690-8. 2005
  8. ncbi ADHD drugs and cardiovascular risk
    Marsha D Rappley
    N Engl J Med 354:2296-8; author reply 2296-8. 2006
  9. ncbi The adrenergic receptor alpha-2A gene (ADRA2A) and neuropsychological executive functions as putative endophenotypes for childhood ADHD
    Irwin D Waldman
    Department of Psychology, Emory University, Atlanta, Georgia 30322, USA
    Cogn Affect Behav Neurosci 6:18-30. 2006

Detail Information

Publications9

  1. ncbi Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder
    Marsha D Rappley
    Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA
    J Dev Behav Pediatr 23:23-30. 2002
    ..These patterns of use demonstrate a compelling need for guidance in psychopharmacological treatment of very young children...
  2. ncbi Clinical practice. Attention deficit-hyperactivity disorder
    Marsha D Rappley
    Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA
    N Engl J Med 352:165-73. 2005
  3. ncbi Attention-deficit/hyperactivity disorder in children and adolescents: interventions for a complex costly clinical conundrum
    Donald E Greydanus
    Department of Pediatrics and Human Development, Michigan State University College of Human Medicine, A110 East Fee Hall, East Lansing, MI 48824, USA
    Pediatr Clin North Am 50:1049-92, vi. 2003
    ..Parents, school officials, and clinicians must work together to help all children and adolescents with ADHD achieve their maximum potential...
  4. ncbi Low blood lead levels associated with clinically diagnosed attention-deficit/hyperactivity disorder and mediated by weak cognitive control
    Joel T Nigg
    Department of Psychology, Michigan State University, East Lansing, Lansing, MI 48824 1116, USA
    Biol Psychiatry 63:325-31. 2008
    ..We examine this relationship in children from a community sample exposed to average background levels of lead who have a diagnosis of ADHD that is established by clinical criteria...
  5. ncbi Psychopharmacology of ADHD in adolescents
    Donald E Greydanus
    College of Human Medicine, Michigan State University, Kalamazoo Center for Medical Studies, Kalamazoo, Michigan 49008-1284, USA
    Adolesc Med 13:599-624. 2002
    ..Medications used to treat comorbidities of ADHD (e.g., depression, anxiety, disruptive disorders) are not considered in this review. Psychopharmacology is a very useful tool as part of the overall management of ADHD in adolescents...
  6. ncbi Neuropsychological executive functions and DSM-IV ADHD subtypes
    Joel T Nigg
    Department of Psychology, Michigan State University, East Lansing 48824-1117, USA
    J Am Acad Child Adolesc Psychiatry 41:59-66. 2002
    ..In the case of boys, the two subtypes may be distinguished by the specificity of motor inhibition deficits to ADHD-C...
  7. ncbi Family adversity in DSM-IV ADHD combined and inattentive subtypes and associated disruptive behavior problems
    Carla A Counts
    Department of Psychology, Florida State University, Tallahassee, USA
    J Am Acad Child Adolesc Psychiatry 44:690-8. 2005
    ..CONCLUSIONS: Family adversity is related to ADHD combined type in children and may be related specifically to ADHD symptoms in addition to conduct disorder symptoms...
  8. ncbi ADHD drugs and cardiovascular risk
    Marsha D Rappley
    N Engl J Med 354:2296-8; author reply 2296-8. 2006
  9. ncbi The adrenergic receptor alpha-2A gene (ADRA2A) and neuropsychological executive functions as putative endophenotypes for childhood ADHD
    Irwin D Waldman
    Department of Psychology, Emory University, Atlanta, Georgia 30322, USA
    Cogn Affect Behav Neurosci 6:18-30. 2006
    ..Implications of the results for evaluating the validity and utility of putative endophenotype measures and for finding candidate gene effects on ADHD are discussed...